
Paul V. Ward
Examiner (ID: 13921, Phone: (571)272-2909 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1623, 1622 |
| Total Applications | 2552 |
| Issued Applications | 1846 |
| Pending Applications | 195 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20645771
[patent_doc_number] => 12600705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Heat shock protein modulators and anti-Huntington disease therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/798699
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30126
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798699 | Heat shock protein modulators and anti-Huntington disease therapeutic agents | Feb 11, 2021 | Issued |
Array
(
[id] => 18369063
[patent_doc_number] => 11649217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
[patent_app_type] => utility
[patent_app_number] => 17/174006
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6064
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174006 | Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof | Feb 10, 2021 | Issued |
Array
(
[id] => 18347442
[patent_doc_number] => 20230135552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Compounds Useful In Inhibiting Ketohexokinase And Methods Of Making And Using The Same
[patent_app_type] => utility
[patent_app_number] => 17/798702
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798702 | Compounds Useful In Inhibiting Ketohexokinase And Methods Of Making And Using The Same | Feb 10, 2021 | Abandoned |
Array
(
[id] => 20525971
[patent_doc_number] => 12544390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Methods to refine cannabinoids
[patent_app_type] => utility
[patent_app_number] => 17/798033
[patent_app_country] => US
[patent_app_date] => 2021-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 906
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798033 | Methods to refine cannabinoids | Feb 5, 2021 | Issued |
Array
(
[id] => 17020854
[patent_doc_number] => 20210244725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => USE OF MANZAMINES AS ANTIPROLIFERATIVE AGENT
[patent_app_type] => utility
[patent_app_number] => 17/168319
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168319 | Use of manzamines as antiproliferative agent | Feb 4, 2021 | Issued |
Array
(
[id] => 17022264
[patent_doc_number] => 20210246135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => INHIBITORS OF RAF KINASES
[patent_app_type] => utility
[patent_app_number] => 17/167599
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/167599 | Inhibitors of RAF kinases | Feb 3, 2021 | Issued |
Array
(
[id] => 18280382
[patent_doc_number] => 20230095854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/796975
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796975 | METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND | Feb 2, 2021 | Abandoned |
Array
(
[id] => 17156071
[patent_doc_number] => 20210317122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11
[patent_app_type] => utility
[patent_app_number] => 17/166737
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166737 | Substituted heterocyclic inhibitors of PTPN11 | Feb 2, 2021 | Issued |
Array
(
[id] => 17274390
[patent_doc_number] => 20210380588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Novel Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/165791
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165791
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165791 | Novel Compounds and Uses Thereof | Feb 1, 2021 | Abandoned |
Array
(
[id] => 17022263
[patent_doc_number] => 20210246134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/163712
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163712 | Compound and photoelectric device, image sensor, and electronic device including the same | Jan 31, 2021 | Issued |
Array
(
[id] => 18228200
[patent_doc_number] => 20230067194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHOD FOR TREATMENT OF ACQUIRED COGNITIVE DEFICITS
[patent_app_type] => utility
[patent_app_number] => 17/794109
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794109 | METHOD FOR TREATMENT OF ACQUIRED COGNITIVE DEFICITS | Jan 26, 2021 | Pending |
Array
(
[id] => 17005280
[patent_doc_number] => 20210236441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => TREATMENT OF SPONDYLOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/158117
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158117 | Treatment of spondyloarthritis | Jan 25, 2021 | Issued |
Array
(
[id] => 18476656
[patent_doc_number] => 11690379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Aqueous insecticidal composition and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/156819
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6666
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156819 | Aqueous insecticidal composition and methods of use thereof | Jan 24, 2021 | Issued |
Array
(
[id] => 18323561
[patent_doc_number] => 20230121689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/759232
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759232 | CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF | Jan 21, 2021 | Pending |
Array
(
[id] => 18284365
[patent_doc_number] => 20230099837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS WITH RIPK1/RIPK3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/792917
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792917 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS WITH RIPK1/RIPK3 INHIBITORS | Jan 21, 2021 | Abandoned |
Array
(
[id] => 17081966
[patent_doc_number] => 20210276972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => Quinazoline Derivatives as VEGF Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/150856
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150856 | Quinazoline Derivatives as VEGF Inhibitors | Jan 14, 2021 | Abandoned |
Array
(
[id] => 18256470
[patent_doc_number] => 20230083509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => POLYACRYLATE-FREE COSMETIC PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/904039
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904039 | POLYACRYLATE-FREE COSMETIC PREPARATION | Jan 13, 2021 | Pending |
Array
(
[id] => 16948059
[patent_doc_number] => 20210206750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN
[patent_app_type] => utility
[patent_app_number] => 17/146801
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146801 | Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan | Jan 11, 2021 | Issued |
Array
(
[id] => 18285000
[patent_doc_number] => 20230100472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => High Triplet Yield Phenothiazine Donor-Acceptor Complexes For Photoredox Catalysis
[patent_app_type] => utility
[patent_app_number] => 17/789874
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789874 | High triplet yield phenothiazine donor-acceptor complexes for photoredox catalysis | Jan 7, 2021 | Issued |
Array
(
[id] => 16964171
[patent_doc_number] => 20210215670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => COMPOUNDS AND METHODS OF IDENTIFYING, SYNTHESIZING, OPTIMIZING AND PROFILING PROTEIN MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/144840
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144840
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144840 | Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators | Jan 7, 2021 | Issued |